Safety and Activity of the Highly Specific BTK Inhibitor BGB-3111 in Patients with Indolent and Aggressive Non Hodgkin's Lymphoma

被引：1
作者：
Tam, Constantine S.
Simpson, David
Opat, Stephen
Kim, Won Seog
Wang, Michael
Cull, Gavin
Johnston, Patrick B.
Munoz, Javier
Lee, Won-Sik
Marlton, Paula
Gottlieb, David
Wang, Lai
Huang, Jane
Hilger, James
Xue, Ling
Ro, Sunhee
Trotman, Judith
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
152
引用
收藏
页数：3
相关论文
共 50 条
[41]   CLINICAL CHARACTARISTICS AND PROGNOSIS OF PATIENTS WITH INDOLENT NON-HODGKIN LYMPHOMA AND RISK OF TRANSFORMATION TO AGGRESSIVE LYMPHOMA: A SINGLE JORDANIAN CENTER EXPERIENCE [J].
Zahran, D. ;
Ayesh , M. ;
Kewan, T. ;
Al Bashir, S. .
HAEMATOLOGICA, 2017, 102 :752-753
[42]   Rituximab improves rate and duration of chemotherapy-induced remissions in indolent and aggressive non-Hodgkin's lymphoma [J].
不详 .
CLINICAL LYMPHOMA, 2004, 5 (02) :81-83
[43]   Comparison of out-of-pocket costs and quality of life (QOL) for patients (pts) with Hodgkin's disease (HD), indolent Non-Hodgkin's lymphoma (INHL) and aggressive Non-Hodgkin's lymphorna (ANHL). [J].
Nonzee, Narissa J. ;
Brown, Sheila O. ;
Chang, Chih-Hung ;
Evens, Andrew M. ;
Gordon, Leo I. ;
Winter, Jane N. ;
Bowman, Lee ;
Kutikova, Lucie ;
Bennett, Charles L. .
BLOOD, 2006, 108 (11) :951A-951A
[44]   Effectiveness and tolerability of radiotherapy for patients with indolent non-Hodgkin’s lymphoma: a monocenter analysis [J].
I. Hadi ;
A. Schummer ;
M. Dreyling ;
C. Eze ;
R. Bodensohn ;
O. Roengvoraphoj ;
C. Belka ;
M. Li .
Scientific Reports, 11
[45]   ECONOMIC EVALUATION OF BENDAMUSTINE IN PATIENTS WITH RELAPSED INDOLENT NON-HODGKIN'S LYMPHOMA IN MEXICO [J].
Salazar, A. ;
Aguirre, A. ;
Herrera, M. .
VALUE IN HEALTH, 2017, 20 (05) :A215-A215
[46]   Modeling and Simulation in Support of Odronextamab Subcutaneous Dose Selection for Adult Patients with Indolent or Aggressive Non-Hodgkin Lymphoma [J].
Zhu, Min ;
Ambati, Srikanth R. ;
Mohamed, Hesham ;
Toroghi, Masood Khaksar ;
Yan, Hong ;
Chaudhry, Aafia ;
Davis, John D. .
BLOOD, 2022, 140 :11579-11580
[47]   Uncertainty and coping in patients with newly diagnosed indolent non-Hodgkin's lymphoma (iNHL) [J].
Newcomb, Richard ;
Johnson, Patrick Connor ;
Yang, Daniel ;
Amonoo, Hermioni L. ;
Dhawale, Tejaswini More ;
Chen, Yi-Bin Albert ;
El-Jawahri, Areej .
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[48]   Population pharmacokinetics of bendamustine and metabolites in patients with indolent non-hodgkin's lymphoma (NHL). [J].
Owen, J. S. ;
Melhem, M. ;
D'Andrea, D. ;
Darwish, M. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 :S54-S55
[49]   Effectiveness and tolerability of radiotherapy for patients with indolent non-Hodgkin's lymphoma: a monocenter analysis [J].
Hadi, I ;
Schummer, A. ;
Dreyling, M. ;
Eze, C. ;
Bodensohn, R. ;
Roengvoraphoj, O. ;
Belka, C. ;
Li, M. .
SCIENTIFIC REPORTS, 2021, 11 (01)
[50]   Introduction: Treatment of patients with rituximab-refractory indolent non-hodgkin's lymphoma [J].
Gregory, Stephanie A. .
SEMINARS IN HEMATOLOGY, 2007, 44 (03) :S1-S1
12345